| Objective:By observing and comparing the clinical efficacy of scalp point penetrating acupuncture combined with ear acupuncture and conventional acupuncture in the treatment of hyperactivity of liver Yang type migraine,to explore the clinical effectiveness and feasibility of scalp point penetrating acupuncture combined with ear acupuncture in the treatment of hyperactivity of liver Yang type migraine.Methods:64 patients with hyperactive liver-yang migraine who met the inclusion criteria were screened and divided into treatment group and control group with 32 patients in each group by random number table method.The treatment group was treated with head point penetrating acupuncture combined with ear acupuncture.The selected points were Sun penetration Valley(affected side),Touwei Touqubin(affected side),Fengchi(affected side),interline(bilateral)and Taixi(bilateral),combined with ear point press acupuncture(forehead,temporal,occipital,liver and kidney).The control group received conventional acupuncture,and the selected points were Taiyang(affected side),Ruigu(affected side),Touwei(affected side),Qubin(affected side),Fengchi(affected side),interline(bilateral)and Taixi(bilateral).The course of milliacupuncture is once a day,5 times a day for a total of 2 courses of treatment,followed by a second course of treatment 2 days after the first course.The ear needle was treated from the first day of the first course of treatment,and the needle was retained once for 4 days,for a total of 3 treatments.The visual analog Pain Scale(VAS),Migraine Symptom Score Scale and Migraine Disability Assessment Questionnaire(MIDAS)were used to observe the clinical efficacy of the two groups.The relevant data were collated and analysed using the statistical software SPSS 26.0to compare the differences in the results between the two groups.Results:1.Baseline situationGeneral data: no differences between the two groups in terms of gender,age,and duration of disease(P> 0.05).Observation index: no statistical difference in scale scores(VAS,migraine symptom score,MIDAS score)(P> 0.05).2.Short-term efficacyVAS score: Compared with before treatment,VAS scores of both groups were significantly decreased after treatment(P<0.01);the VAS scores of the treatment group decreased much more than those of the control group(P<0.01).Migraine symptom score: Compared with those before treatment,the migraine symptom scores of patients in both groups were significantly reduced after treatment(P < 0.01);the reduction of migraine symptom scores in the treatment group was much greater than that in the control group(P < 0.01).MIDAS score: Compared to the pre-treatment period,the MIDAS scores of both groups were significantly lower after treatment(P < 0.01);at the end of treatment,MIDAS scores in the treatment group decreased much more than those in the control group(P < 0.01).Recent overall efficacy(total effective rate): 93.75% in the treatment group and81.25% in the control group;the difference in the short-term overall efficacy between the two groups was highly statistically significant(P<0.01).3.Long-term curative effectVAS score:Compared with the pre-treatment period,the VAS scores of patients in both groups decreased significantly at 1 month after treatment(P < 0.01);the reduction of VAS scores at 1 month after treatment was much greater in the treatment group than in the control group(P < 0.01)Migraine symptom score: Compared with those before treatment,the migraine symptom scores in both groups were substantially reduced 1 month after treatment(P< 0.01);the reduction in migraine symptom scores in the treatment group 1 month after treatment was much greater than that in the control group(P < 0.01).MIDAS score: Compared with the pre-treatment period,the MIDAS score of both groups decreased significantly at 1 month after treatment(P < 0.01);the MIDAS score of the treatment group decreased much more than that of the control group at 1month after treatment(P < 0.01).Long-term overall efficacy(total effective rate): 81.25% in the treatment group and 68.75% in the control group 1 month after treatment,with highly statistically significant differences in the long-term overall efficacy between the two groups(P<0.01).Conclusion:1.The two groups of treatment methods have clinical effects on patients with hyperactive liver-yang type migraine.The short-term and long-term overall efficacy of head point penetration acupuncture combined with ear acupuncture on patients with hyperactive liver-yang type migraine is superior to conventional acupuncture.2.Head point penetration acupuncture combined with ear acupuncture can more effectively improve migraine symptoms,health status and quality of life of patients with hyperactive liver-yang migraine,both short-term and long-term efficacy are better than conventional acupuncture;3.The efficacy of head point penetration acupuncture combined with ear acupuncture in the treatment of hyperactivity of liver Yang type migraine has certain value in the study of pain syndrome treatment,providing ideas for the clinical treatment of migraine.The two acupuncture methods are simple and easy,effective quickly,economical and applicable,safe and without side effects,and can be used as one of the common methods for the treatment of migraine,which is worth promoting clinically. |
PDF Full Text Request